In The News,
ADVI’s Lindsay Bealor Greenleaf talks to Bloomberg Law about Drug Pricing Reform Expectations Under the 116th Congress
[el-text]
Written by Jacquie Lee
***excerpt***
Voters should expect to see a partisan approach to tackling drug prices in 2019 and into 2020, Lindsay Bealor Greenleaf said, with Democrats’ focusing mainly on drug companies and Republicans looking at pharmacy benefit managers and other players in the supply chain, she said.
***end excerpt***
***
[/el-text]